Caribou Biosciences


ATLANTA, GA – – (Newsfile Corp. – February 13, 2023) – – Holzer & Holzer, LLC informs investors that a class action lawsuit has been filed against Caribou Biosciences, Inc. (“Caribou Biosciences” or the “Company”) (NASDAQ: CRBU).  The lawsuit alleges Caribou Biosciences made materially false and/or misleading statements and/or failed to disclose material adverse facts in its offering documents and throughout the Class Period, including: (i) Caribou Bioscience’s product candidate, known as CB-010, had a treatment effect that was not as durable as Defendants had led investors to believe; (ii) accordingly, CB-010’s clinical and commercial prospects were overstated.

If you bought shares of Caribou Biosciences between July 23, 2021, and December 9, 2022 and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey Holzer, Esq. at or Joshua Karr, Esq. at, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is April 11, 2023.

Registration Deadline

Lead Plaintiff Deadline Has Passed

April 11, 2023

Submit Your Information

Shares Purchased(Required)
Date of Shares Purchased
Number of Shares Acquired
Acquisition Price Per Share
Shares Sold
Date of Shares Sold
Number of Shares Sold
Selling Price Per Share